Twist Bioscience Corp — Director's Dealing 2020

Jan 10, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-01-07

Reporting Person: Weiss Patrick (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	50438	Direct
Common Stock	40608	Direct
Common Stock	9270	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$5.95	2025-09-28	Common Stock (1052)		Direct
Employee Stock Option (right to buy)	$8.82	2027-09-28	Common Stock (54707)		Direct
Employee Stock Option (right to buy)	$26.66	2028-11-18	Common Stock (102432)		Direct
Employee Stock Option (right to buy)	$25.02	2029-12-09	Common Stock (39710)		Direct

Footnotes

F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 12/60th of the shares subject to the RSU Award vesting on November 20, 2019 and 1/20th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F2: Represents a RSU that vests in installments, with 25% of the shares subject to the RSU Award vesting on December 9, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F3: The option is immediately exercisable. 25% of the shares subject to the option vest on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F4: The option is immediately exercisable. 10% of the shares subject to the option vest on September 29, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F5: 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F6: 25% of the shares subject to the option vest and become exercisable on December 9, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date.